Menarini India signs pact with Pierre Fabre Laboratories
To market Eau Thermale Avene and Ducray in India
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Market
Eugia Pharma gets USFDA nod for posaconazole injection, 300 mg/16.7 mL, single-dose vial
The approved product has an estimated market size of $25.4 million for the twelve months ending October 2023, according to IQVIA
Informa Markets organises CPHI & PMEC India 2023 successfully at India Expo Centre
CPHI and PMEC India expo attracted over 48,000 attendees from 120+ countries and over 1,500 exhibitors
AstraZeneca to acquire Gracell Biotechnologies
Deal includes clinical-stage autologous BCMA/CD19 CAR-T therapy targeting haematologic malignancies and autoimmune diseases, and…
Ractigen’s RAG-01 becomes second saRNA drug globally to advance to clinical stage: GlobalData
RAG-01 has shown promising results in preclinical tumor suppression and a solid safety profile
Intas Pharma signs licensing pact with mAbxience for etanercept biosimilar
Intas gains exclusive commercialisation rights for Etanercept biosimilar for more than 150 countries worldwide
Indian Immunologicals celebrates 25 years of Human Biologicals, launches measles and rubella vaccine
This live attenuated MR vaccine has been developed by IIL in an exclusive partnership with Polyvac Institute, Vietnam
New CAR-T therapies in South Korea to face stringent regulatory oversight: GlobalData
The Korean Ministry of Food and Drug Safety (MFDS) has recently mandated the reporting of any suspected adverse reactions,…
Granules India gets ANDA approval for Pantoprazole Sodium DR tablets
Pantoprazole Sodium delayed-release tablets are indicated for short-term treatment of erosive esophagitis associated with GERD
Sterling Accuris acquires Vaibhav Analytical Services, expands into pharma and analytical testing
With this acquisition, Sterling Accuris has expanded its range of services offered to fields such as pharma analytical testing
Sanofi’s $140 mn investment in Aqemia will accelerate drug discovery through AI: GlobalData
The collaboration is poised to help reshape the landscape of drug development and improve the way new therapeutic compounds are…
Coya, Dr Reddy’s sign pact to develop and market COYA 302 for treatment of ALS
Coya retains the right to commercialise COYA 302 for patients with amyotrophic lateral sclerosis (ALS) in Japan, Mexico, and each…
Future-proofing the pharma cold chain
As India's pharma sector undergoes a transformative shift, an agile and scalable cold chain characterised by innovative…
Zydus, Daewoong sign licensing pact to develop, market Leuprolide long-acting injectable in US
Leuprolide acetate for depot suspension is a GnRH agonist used for the treatment of advanced prostatic cancer, endometriosis, and…
Madrigal’s efforts for resmetirom will set tone for future launches of NASH therapies: GlobalData
In December 2022, the company successfully concluded raising a total of $309 million following positive topline data from the…
Merck announces Remarkable Merck Young Scientists Awards 2023
Held at Bangalore, the annual awards recognise the work of young scientists who are driving positive change in the lives of…
Indoco Remedies gets tentative USFDA approval for Canagliflozin Tablets
Canagliflozin improves glycemic control in adults with type 2 diabetes mellitus
Zydus gets final USFDA nod for Methylene Blue Injection
Methylene Blue Injection is an oxidation-reduction agent indicated for the treatment of pediatric and adult patients with acquired…
Venus Remedies gets marketing approvals from Philippines, Saudi Arabia for three drugs
While Saudi Arabia is the largest pharma market in GCC region, Philippines happens to be the second largest market in South East…
Sentynl completes asset transfer of CUTX-101 Copper Histidinate product candidate for treatment of…
A rolling submission of the CUTX-101 New Drug Application (NDA) to the FDA is ongoing, with expected completion in 2024